Compounds for the treatment of spinal muscular atrophy and other uses
View Patent ↗Compounds of Formula (I) or (II) useful for the treatment of spinal muscular atrophy or other uses, as well as methods of using such compounds to increase SMN expression, increase EAAT2 expression, or increase the expression of a nucleic acid that encodes a translational stop codon introduced by mutation or frameshift.
1. A compound of Formula I:
wherein,
W is C(O) or C(S);
B is CH 2 or CH(CH n H 2n+1 ), wherein n is an integer from 1 to 8;
R 1 and R 2 are independently selected from the group consisting of H and C 1 -C 3 alkyl, or R 1 and R 2 may be taken together with the carbon atom to which they are attached to form a C 3 -C 6 cycloalkyl ring or a carbonyl group;
R 3 is selected from the group consisting of H, halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 haloalkoxy, C 2 -C 6 alkenyl, CN, NO 2 , heteroaryl, and phenyl optionally substituted with any combination of one to five halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, or C 1 -C 4 alkoxy;
R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of H, hydroxyl, halogen, CN, NO 2 , sulfonamide, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 haloalkoxy, C 2 -C 8 alkenyl, amino, C 1 -C 4 dialkyl amino, C 1 -C 4 alkylamino, C 3 -C 6 cycloalkylamino, morpholinyl, heteroaryl, arylamino, arylalkylamino, phenyl, C(O)R′, NR′(COR″), NR′SO 2 R″ and NR′(CONR″R′″); wherein R′, R″ and R′″ are independently H, C 1 -C 6 alkyl, phenyl or substituted phenyl; and wherein the C 1 -C 8 alkyl is optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, arylamino, arylalkylamino, and morpholinyl; and the phenyl is optionally substituted with one or more members selected from the group consisting of halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, and C 1 -C 4 alkoxy;
wherein at least R 5 , R 6 , or both are further selected from the group consisting of hydroxyl, halogen, CN, NO 2 , sulfonamide, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 haloalkoxy, C 2 -C 8 alkenyl, amino, C 1 -C 4 dialkyl amino, C 1 -C 4 alkylamino, C 3 -C 6 cycloalkylamino, morpholinyl, heteroaryl, arylamino, arylalkylamino, phenyl, C(O)R′, NR′(COR″), NR′SO 2 R″ and NR′(CONR″R′″); wherein the C 1 -C 8 alkyl is optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, arylamino, arylalkylamino, and morpholinyl; and the phenyl is optionally substituted with one or more members selected from the group consisting of halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, and C 1 -C 4 alkoxy;
or R 4 and R 5 , R 5 and R 6 , or R 6 and R 7 taken together with the carbon atoms to which they are attached form a dioxane or dioxolane ring;
X is selected from the group consisting of
H;
CN;
C(O)NR 9 R 10 or CH 2 NR 9 R 10 , wherein R 9 and R 10 are independently selected from the group consisting of H and C 1 -C 6 alkyl, or R 9 and R 10 together with the nitrogen to which they are attached faun a C 5 -C 6 cycloalkyl ring or a heteroring such as morphline;
CH 2 OR 11 , wherein R 11 is H, C 1 -C 8 alkyl, or C 3 -C 6 cycloalkyl, wherein the C 1 -C 8 alkyl optionally is substituted with one or members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, and morpholinyl;
CH 2 Z, wherein Z is halogen;
C(O)NHOH;
C(O)NHCN;
C(O)N(R 1 )SO 2 R 13 , wherein R 13 is C 1 -C 4 alkyl, phenyl, or substituted phenyl;
C 1 -C 8 alkyl, optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkylamino, and C 1 -C 6 alkylamino; and
C 2 -C 8 alkenyl optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkylamino, and C 1 -C 6 alkylamino.
2. The compound of claim 1 , wherein:
B is CH 2 ;
R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of H, halogen, CN, NO 2 , sulfonamide, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 4 haloalkyl, amino, C 1 -C 4 dialkyl amino, C 1 -C 4 alkylamino, C 3 -C 6 cycloalkyl amino, morpholinyl, heteroaryl, and phenyl, wherein the C 1 -C 8 alkyl is optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, and morpholinyl, and the phenyl is optionally substituted with one or more members selected from the group consisting of halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, and C 1 -C 4 alkoxy;
wherein at least R 5 , R 6 , or both are further selected from the group consisting of halogen, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 4 dialkyl amino, C 1 C 4 alkylamino, C 3 -C 6 cycloalkyl amino, and morpholinyl, wherein the C 1 -C 8 alkyl is optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, and morpholinyl;
X is selected from the group consisting of
CN;
C(O)NR 9 R 10 or CH 2 NR 9 R 10 , wherein R 9 and R 10 are independently selected from the group consisting of H and C 1 -C 6 alkyl, or R 9 and R 10 together with the nitrogen to which they are attached form a C 5 -C 6 cycloalkyl ring or a heteroring such as morphline;
CH 2 OR 11 , wherein R 11 is H, C 1 -C 8 alkyl, or C 3 -C 6 cycloalkyl, wherein the C 1 -C 8 alkyl optionally is substituted with one or members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, and morpholinyl;
CH 2 Z, wherein Z is halogen;
C(O)NHOH;
C(O)NHCN;
C(O)N(R 1 )SO 2 R 13 , wherein R 13 is C 1 -C 4 alkyl, phenyl, or substituted phenyl;
C 1 -C 8 alkyl, optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkylamino, and C 1 -C 6 alkylamino; and
C 2 -C 8 alkenyl optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkylamino, and C 1 -C 6 alkylamino.
3. The compound of claim 1 , wherein X is selected from the group consisting of
CN;
CH 2 OR 11 , wherein R 11 is H, C 1 -C 8 alkyl, or C 3 -C 6 cycloalkyl, wherein the C 1 -C 8 alkyl optionally is substituted with one or members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, and morpholinyl;
C 1 -C 8 alkyl, optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkylamino, and C 1 -C 6 alkylamino.
4. The compound of claim 1 , wherein R 1 and R 2 are independently selected from the group consisting of H and C 1 -C 3 alkyl.
5. The compound of claim 1 , wherein R 5 and R 6 are independently selected from the group consisting of halogen, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 4 haloalkyl, amino, C 1 -C 4 dialkyl amino, C 1 -C 4 alkylamino, C 3 -C 6 cycloalkyl amino, and morpholinyl, wherein the C 1 -C 8 alkyl is optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, and morpholinyl.
6. The compound of claim 1 , wherein R 7 is selected from the group consisting of halogen, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 4 haloalkyl, amino, C 1 -C 4 dialkyl amino, C 1 -C 4 alkylamino, C 3 -C 6 cycloalkyl amino, and morpholinyl, wherein the C 1 -C 8 alkyl is optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, and morpholinyl.
7. The compound of claim 1 , wherein X is selected from the group consisting of
CN;
C(O)NR 9 R 10 , wherein R 9 and R 10 are independently selected from the group consisting of H and C 1 -C 6 alkyl, or R 9 and R 10 together with the nitrogen to which they are attached form a C 5 -C 6 cycloalkyl ring or a heteroring such as morphline;
CH 2 OR 11 , wherein R 11 is H, C 1 -C 8 alkyl, or C 3 -C 6 cycloalkyl, wherein the C 1 -C 8 alkyl optionally is substituted with one or members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, and morpholinyl;
CH 2 NR 9 R 10 , wherein R 9 and R 10 are as defined above,
CH 2 Z, wherein Z is halogen;
C(O)NHOH;
C(O)NHCN; and
C(O)N(R 1 )SO 2 R 13 , wherein R 13 is C 1 -C 4 alkyl, phenyl, or substituted phenyl.
8. The compound of claim 7 , wherein X is selected from the group consisting of
CN;
CH 2 OR 11 , wherein R 11 is H, C 1 -C 8 alkyl, or C 3 -C 6 cycloalkyl, wherein the C 1 -C 8 alkyl is optionally substituted one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, and morpholinyl;
CH 2 NR 9 R 10 , wherein R 9 and R 10 are independently selected from the group consisting of H and C 1 -C 6 alkyl, or R 9 and R 10 together with the nitrogen to which they are attached form a C 5 -C 6 cycloalkyl ring or a heteroring such as morphline; and
CH 2 Z, wherein Z is halogen.
9. The compound of claim 1 , wherein X is selected from the group consisting of
C 1 -C 8 alkyl, optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkylamino, and C 1 -C 6 alkylamino; and
C 1 -C 8 alkenyl, optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkylamino, and C 1 -C 6 alkylamino.
10. A compound according to claim 1 , wherein the compound is:
11. A composition comprising a compound of claim 1 , and a carrier.
12. A compound of Formula I:
wherein,
W is C(O) or C(S);
B is CH 2 or CH(C n H 2n+1 ), wherein n is an integer from 1 to 8;
R 1 and R 2 are independently selected from the group consisting of H and C 1 -C 3 alkyl, or R 1 and R 2 may be taken together with the carbon atom to which they are attached to form a C 3 -C 6 cycloalkyl ring or a carbonyl group;
R 3 is selected from the group consisting of H, halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 haloalkoxy, C 2 -C 6 alkenyl, CN, NO 2 , heteroaryl, and phenyl optionally substituted with any combination of one to five halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, or C 1 -C 4 alkoxy;
R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of H, hydroxyl, halogen, CN, NO 2 , sulfonamide, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 haloalkoxy, C 2 -C 8 alkenyl, amino, C 1 -C 4 dialkyl amino, C 1 -C 4 alkylamino, C 3 -C 6 cycloalkylamino, morpholinyl, heteroaryl, arylamino, arylalkylamino, phenyl, C(O)R′, NR′(COR″), NR′SO 2 R″ and NR′(CONR″R′″); wherein R′, R″ and R′″ are independently H, C 1 -C 6 alkyl, phenyl or substituted phenyl; and wherein the C 1 -C 8 alkyl is optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, arylamino, arylalkylamino, and morpholinyl; and the phenyl is optionally substituted with one or more members selected from the group consisting of halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, and C 1 -C 4 alkoxy;
wherein at least one of R 4 , R 5 , R 6 and R 7 is selected from the group consisting of CN, NO 2 , sulfonamide, C 3 -C 6 cycloalkyl, C 1 -C 4 haloalkyl, C 1 -C 6 haloalkoxy, C 2 -C 8 alkenyl, amino, C 1 -C 4 dialkyl amino, C 1 -C 4 alkylamino, C 3 -C 6 cycloalkylamino, morpholinyl, heteroaryl, arylamino, arylalkylamino, phenyl, C(O)R′, NR′(COR″), NR′(COR″) NR′SO 2 R″, NR′(CONR″R′″), and C 1 -C 8 alkyl substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, arylamino, arylalkylamino, and morpholinyl; wherein R′, R″ and R″ are independently H, C 1 -C 6 alkyl, and phenyl optionally substituted with one or more members selected from the group consisting of halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, and C 1 -C 4 alkoxy;
or R 4 and R 5 , R 5 and R 6 , or R 6 and R 7 taken together with the carbon atoms to which they are attached form a dioxane or dioxolane ring;
X is
C(O)0R 8 , wherein R 8 is H or C 1 -C 8 alkyl wherein the alkyl optionally is substituted with one or members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, phenyl, and morpholinyl.
13. A compound of claim 12 , wherein the compound is:
14. A compound of Formula I:
wherein,
W is C(O) or C(S);
B is CH 2 or CH(C n H 2n+1 ), wherein n is an integer from 1 to 8;
R 1 and R 2 are independently selected from the group consisting of H and C 1 -C 3 alkyl, or R 1 and R 2 may be taken together with the carbon atom to which they are attached to form a C 3 -C 6 cycloalkyl ring or a carbonyl group;
R 3 is selected from the group consisting of H, halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 haloalkoxy, C 2 -C 6 alkenyl, CN, NO 2 , heteroaryl, and phenyl optionally substituted with any combination of one to five halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, or C 1 -C 4 alkoxy;
R 4 , R 5 , and R 6 are independently selected from the group consisting of H, hydroxyl, halogen, CN, NO 2 , sulfonamide, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 haloalkoxy, C 2 -C 8 alkenyl, amino, C 1 -C 4 dialkyl amino, C 1 -C 4 alkylamino, C 3 -C 6 cycloalkylamino, morpholinyl, heteroaryl, arylamino, arylalkylamino, phenyl, and C(O)R′, NR′(COR″), NR′SO 2 R″ and NR′(CONR″R′″); wherein R′, R″ and R′″ are independently H, C 1 -C 6 alkyl, phenyl or substituted phenyl; and wherein the C 1 -C 8 alkyl is optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, arylamino, arylalkylamino, and morpholinyl; and the phenyl is optionally substituted with one or more members selected from the group consisting of halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, and C 1 -C 4 alkoxy;
R 7 is selected from the group consisting of H, CN, sulfonamide, C 1 -C 8 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 haloalkoxy, C 2 -C 8 alkenyl, C 1 -C 4 dialkyl amino, C 1 -C 4 alkylamino, C 3 -C 6 cycloalkylamino, morpholinyl, heteroaryl, arylamino, arylalkylamino, phenyl, and C(O)R′, NR′(COR″), NR′SO 2 R″ and NR′(CONR″R′″); wherein R′, R″ and R′″ are independently H, C 1 -C 6 alkyl, phenyl or substituted phenyl; and wherein the C 1 -C 8 alkyl is optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, arylamino, arylalkylamino, and morpholinyl; and the phenyl is optionally substituted with one or more members selected from the group consisting of halogen, NO 2 , CN, C 1 -C 4 alkyl, C 1 -C 1 haloalkyl, and C 1 -C 1 alkoxy;
or R 4 and R 5 , R 5 and R 6 , or R 6 and R 7 taken together with the carbon atoms to which they are attached form a dioxane or dioxolane ring;
X is selected from the group consisting of
H;
CN;
C(O)NR 9 R 10 or CH 2 NR 9 R 10 , wherein R 9 and R 10 are independently selected from the group consisting of H and C 1 -C 6 alkyl, or R 9 and R 10 together with the nitrogen to which they are attached form a C 5 -C 6 cycloalkyl ring or a heteroring such as morphline;
CH 2 OR 11 , wherein R 11 is H, C 1 -C 8 alkyl, or C 3 -C 6 cycloalkyl, wherein the C 1 -C 8 alkyl optionally is substituted with one or members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkyl amino, C 1 -C 6 alkylamino, cycloalkylamino, and morpholinyl;
CH 2 Z, wherein Z is halogen;
C(O)NHOH;
C(O)NHCN;
C(O)N(R 1 )SO 2 R 13 , wherein R 13 is C 1 -C 4 alkyl, phenyl, or substituted phenyl;
C 1 -C 8 alkyl, optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, haloalkyl, C 1 -C 6 dialkylamino, and C 1 -C 6 alkylamino; and
C 2 -C 8 alkenyl optionally substituted with one or more members selected from the group consisting of C 1 -C 4 alkoxy, C 1 -C 4 haloalkyl, C 1 -C 6 dialkylamino, and C 1 -C 6 alkylamino;
wherein at least one of R 4 , R 5 , R 6 and R 7 is not H.
15. A compound of claim 14 , wherein the compound is: